Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro

BACKGROUND: Canine oral fibrosarcoma (COF) is one of the most common oral tumors in dogs and carries a guarded prognosis due to a lack of effective systemic therapeutic options. Mastinib and imatinib are two commonly used tyrosine kinase inhibitors (TKIs) in veterinary oncology but their potential e...

Descripción completa

Detalles Bibliográficos
Autores principales: Milovancev, Milan, Helfand, Stuart C., Marley, Kevin, Goodall, Cheri P., Löhr, Christiane V., Bracha, Shay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893279/
https://www.ncbi.nlm.nih.gov/pubmed/27259510
http://dx.doi.org/10.1186/s12917-016-0712-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893279/
https://www.ncbi.nlm.nih.gov/pubmed/27259510
http://dx.doi.org/10.1186/s12917-016-0712-x

Ejemplares similares